Browsing by Author "Christoph Hammerle"

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • No Thumbnail Available
    PublicationMetadata only
    Group 1 ITI Consensus Report: The influence of implant length and design and medications on clinical and patient-reported outcomes
    (2018-10-01) Ronald E. Jung; Bilal Al-Nawas; Mauricio Araujo; Gustavo Avila-Ortiz; Stephen Barter; Nadine Brodala; Vivianne Chappuis; Bo Chen; Andre De Souza; Ricardo Faria Almeida; Stefan Fickl; Gary Finelle; Jeffrey Ganeles; Hadi Gholami; Christoph Hammerle; Simon Jensen; Asbjørn Jokstad; Hideaki Katsuyama; Johannes Kleinheinz; Chatchai Kunavisarut; Nikos Mardas; Alberto Monje; Panos Papaspyridakos; Michael Payer; Eik Schiegnitz; Ralf Smeets; Martina Stefanini; Christiaan ten Bruggenkate; Konstantinos Vazouras; Hans Peter Weber; Dieter Weingart; Péter Windisch; Klinikum Stuttgart Katharinenhospital; Universitat Internacional de Catalunya; Tufts University School of Dental Medicine; Johannes Gutenberg Universität Mainz; Universidade Estadual de Maringa; Alma Mater Studiorum Università di Bologna; Universidad Complutense de Madrid; Semmelweis Egyetem; Barts and The London School of Medicine and Dentistry; UiT The Arctic University of Norway; University of Bern; Nova Southeastern University; University of Toronto; Copenhagen University Hospital; Peking University; Mahidol University; Julius-Maximilians-Universität Würzburg; University of Zurich; Universidade do Porto; Universitätsklinikum Münster; Medizinische Universität Graz; University of Iowa College of Dentistry; Universitätsklinikum Hamburg-Eppendorf und Medizinische Fakultät; Tokyo Medical and Dental University; Amsterdam UMC - Vrije Universiteit Amsterdam; Gary Finelle; Private Practice; Florida Institute for Periodontics and Dental Implants; Private Practice
    © 2018 The Authors. Clinical Oral Implants Research Published by John Wiley & Sons Ltd. Objectives: The aim of Working Group 1 was to address the influence of different local (implant length, diameter, and design) and systemic (medications) factors on clinical, radiographic, and patient-reported outcomes in implant dentistry. Focused questions on (a) short posterior dental implants (≤6 mm), (b) narrow diameter implants, (c) implant design (tapered compared to a non-tapered implant design), and (d) medication-related dental implant failures were addressed. Materials and methods: Four systematic reviews were prepared in advance of the Consensus Conference and were discussed among the participants of Group 1. Consensus statements, clinical recommendations, and recommendations for future research were based on structured group discussions until consensus was reached among the entire expert Group 1. The statements were then presented and accepted following further discussion and modifications as required by the plenary. Results: Short implants (≤6 mm) revealed a survival rate ranging from 86.7% to 100%, whereas standard implant survival rate ranged from 95% to 100% with a follow-up from 1 to 5 years. Short implants demonstrated a higher variability and a higher Risk Ratio [RR: 1.24 (95% CI: 0.63, 2.44, p = 0.54)] for failure compared to standard implants. Narrow diameter implants (NDI) have been classified into three categories: Category 1: Implants with a diameter of <2.5 mm (“Mini-implants”); Category 2: Implants with a diameter of 2.5 mm to <3.3 mm; Category 3: Implants with a diameter of 3.3 mm to 3.5 mm. Mean survival rates were 94.7 ± 5%, 97.3 ± 5% and 97.7 ± 2.3% for category 1, 2 and 3. Tapered versus non-tapered implants demonstrated only insignificant differences regarding clinical, radiographic, and patient-reported outcomes. The intake of certain selective serotonin reuptake inhibitors and proton pump inhibitors is associated with a statistically significant increased implant failure rate. The intake of bisphosphonates related to the treatment of osteoporosis was not associated with an increased implant failure rate. Conclusions: It is concluded that short implants (≤6 mm) are a valid option in situations of reduced bone height to avoid possible morbidity associated with augmentation procedures; however, they reveal a higher variability and lower predictability in survival rates. Narrow diameter implants with diameters of 2.5 mm and more demonstrated no difference in implant survival rates compared to standard diameter implants. In contrast, it is concluded that narrow diameter implants with diameters of less than 2.5 mm exhibited lower survival rates compared to standard diameter implants. It is further concluded that there are no differences between tapered versus non-tapered dental implants. Certain medications such as selective serotonin reuptake inhibitors and proton pump inhibitors showed an association with a higher implant failure rate.